An estimated 200 million adults in the U.S. (a staggering 68% of the adult
population) are categorized as overweight or obese. Obesity is the,
second-leading cause of preventable death in the U.S. resulting in nearly
112,000 deaths annually. The condition is a leading cause of type 2 diabetes,
disability, and heart disease, and is a significant contributor to rising
healthcare costs. Despite the dire need for weight loss in the majority of the
adult population, research has found that diet and exercise alone is
unsuccessful in 80-85% of patients at one year, and only approximately 1% of
the eligible obese population currently undergoes bariatric surgery due to
high cost and high risk of complications. This presents a significant unmet
need for less invasive weight loss treatments. Although more clinical research
is required, minimally invasive bariatric surgical devices and systems may
provide a less costly, safe and effective - and potentially lifesaving -
weight loss alternative.
While current economic conditions continue to restrain market growth, the U.S.
market for minimally invasive bariatric surgical devices is expected to
exhibit relatively strong growth over the next 5 years. Valued at more than
$345 million in 2010, the U.S. minimally invasive bariatric surgical products
market is expected to increase at a healthy compound annual rate of 6.6%, with
sales reaching more than $500 million in 2016.
The market is expected to benefit from increased utilization of laparoscopic
adjustable gastric banding systems and emerging incisionless technologies,
including intragastric balloons and other transorally inserted weight loss
devices, as well as implantable gastric stimulators or vagal blocking systems.
The market is also expected to benefit from growing usage of single-incision
surgery; minimally invasive robotic surgery is also expected to continue to
significantly improve bariatric surgical outcomes.
This dynamic report from Medtech Insight includes analyses of products,
markets, competitors, and emerging technology and opportunities. Covered
topics in this report include laparoscopic adjustable gastric banding (LAGB)
systems; intragastric balloon systems; emerging transorally inserted weight
loss devices; single-incision technologies; minimally invasive robotic
systems; and implantable gastric stimulation/vagal blocking systems.
Methodology
Reports are produced exclusively by Medtech Insight, through extensive primary
and secondary research among the clinicians, researchers, and competitors in
the marketplace, and draw upon the industry expertise of a network of industry
insiders. Medtech Insight exhaustively corroborates the data as a baseline for
completing forward-looking analysis and providing insight into product,
technology and market evolution.
Report Statistics
Date Published: March 2011
Total Number of Pages: 232
Total Number of Exhibits: 87
Total Number of Company Profiles: 12
Table of Contents
Table of Contents
EXECUTIVE SUMMARY
i. Causes of Obesity
ii. Health Risks
iii. Statistics
iv. Minimally Invasive Bariatric Surgical Devices Market
v. Methodology
Exhibit ES-1: Body Mass Index and Obesity
Exhibit ES-2: Surgeon General' s Call to Action to Prevent and Decrease
Overweight and Obesity
Exhibit ES-3: Trends in Overweight, Obesity, and Morbid Obesity, 1988-2008
Exhibit ES-4: Trends in Overweight, Obesity, and Morbid Obesity, 1960-2008
Exhibit ES-5: Prevalence of Obesity Among Men, by Race/Ethnicity,
1988-1994 and 2007-2008
Exhibit ES-6: Prevalence of Obesity Among Women, by Race/Ethnicity,
1988-1994 and 2007-2008
U.S. Market for Minimally Invasive Bariatric Surgical Devices published by Medtech Insight in March 24, 2011. This report consists of 232 Pages and the price starts from US $ 4750.
